- Corporate Officers - L
- Lopez Esteban
Insider Trading History of Lopez Esteban
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lopez Esteban since 2022.
This trader's CIK number is 1839999.
At the time of last reporting, Lopez Esteban was the Officer of Addus Homecare Corp. (stock ticker symbol ADUS).
Also see all insider trading activities at Addus Homecare Corp.
Note that in the past
Lopez Esteban also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Axonics, Inc. (AXNX) by Lopez Esteban
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | AXNX | 0 | $0 | 2,000 | $134,840 | 0 | $0 |
Yearly summary of insider trading at Addus Homecare Corp (ADUS) by Lopez Esteban
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | ADUS | 0 | $0 | 1,000 | $128,765 | 0 | $0 |
| 2022 | ADUS | 0 | $0 | 1,100 | $104,500 | 0 | $0 |
Insider trading activities at 2 companies by Lopez Esteban:
1. Axonics, Inc. (AXNX)
2. Addus Homecare Corp (ADUS)
Table 1. Insider trading of Axonics, Inc. (AXNX) by Lopez Esteban
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-12-13 | AXNX | Sale | 2,000 | 67.42 | 134,840 |
Table 2. Insider trading of Addus Homecare Corp (ADUS) by Lopez Esteban
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-09-10 | ADUS | Sale | 500 | 127.50 | 63,750 |
| 2024-09-04 | ADUS | Sale | 500 | 130.03 | 65,015 |
| 2022-08-15 | ADUS | Sale | 1,100 | 95.00 | 104,500 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Lopez Esteban
(Officer of Addus Homecare Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.